company background image
532482 logo

Granules India BSE:532482 Stock Report

Last Price

₹527.10

Market Cap

₹127.8b

7D

1.2%

1Y

70.6%

Updated

23 Jul, 2024

Data

Company Financials +

Granules India Limited

BSE:532482 Stock Report

Market Cap: ₹127.8b

532482 Stock Overview

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly.

532482 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends5/6

Granules India Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Granules India
Historical stock prices
Current Share Price₹527.10
52 Week High₹530.40
52 Week Low₹287.55
Beta0.36
11 Month Change7.32%
3 Month Change26.18%
1 Year Change70.64%
33 Year Change44.53%
5 Year Change482.43%
Change since IPO17,181.97%

Recent News & Updates

Recent updates

Shareholder Returns

532482IN PharmaceuticalsIN Market
7D1.2%0.2%-2.0%
1Y70.6%47.9%42.8%

Return vs Industry: 532482 exceeded the Indian Pharmaceuticals industry which returned 47.4% over the past year.

Return vs Market: 532482 exceeded the Indian Market which returned 43.8% over the past year.

Price Volatility

Is 532482's price volatile compared to industry and market?
532482 volatility
532482 Average Weekly Movement5.1%
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement6.4%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 532482's share price has been volatile over the past 3 months.

Volatility Over Time: 532482's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19844,057Krishna Chigurupatiwww.granulesindia.com

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology.

Granules India Limited Fundamentals Summary

How do Granules India's earnings and revenue compare to its market cap?
532482 fundamental statistics
Market cap₹127.75b
Earnings (TTM)₹4.05b
Revenue (TTM)₹45.06b

31.5x

P/E Ratio

2.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
532482 income statement (TTM)
Revenue₹45.06b
Cost of Revenue₹21.31b
Gross Profit₹23.76b
Other Expenses₹19.70b
Earnings₹4.05b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 30, 2024

Earnings per share (EPS)16.72
Gross Margin52.72%
Net Profit Margin8.99%
Debt/Equity Ratio37.9%

How did 532482 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

9%

Payout Ratio

Does 532482 pay a reliable dividends?

See 532482 dividend history and benchmarks
When do you need to buy 532482 by to receive an upcoming dividend?
Granules India dividend dates
Ex Dividend DateJul 30 2024
Dividend Pay DateSep 05 2024
Days until Ex dividend6 days
Days until Dividend pay date43 days

Does 532482 pay a reliable dividends?

See 532482 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.